Whereas, BSE Healthcare index showed a nominal growth of 1.10% in the same period.
A look at some leading Pharma funds suggests that they have been underperformers in terms of one year gains.
SBI Pharma Fund just gave a return of 1.74%, which is still better than BSE Healthcare index and holds the top position among its peers.
On the other hand, Tata India Pharma & Healthcare Fund – Regular Plan has turned out to be the worst performer with negative returns of 8.27% to its investors in the past one year.
|Fund name||1 year return (%)||Net Assets (Cr)|
|SBI Pharma Fund||1.74||1008|
|Reliance Pharma Fund||0.76||1456|
|UTI Pharma & Healthcare Fund||0.39||312|
|Tata India Pharma & Healthcare Fund – Regular Plan||(8.27)||80|